reports
- Ahmed Ben Salem
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
ADS ADIDAS AG
PUM PUMA SE
F3C SFC ENERGY AG
ENI ENI S.P.A.
REP REPSOL SA
CCC CCC SA
SAE SHOP APOTHEKE EUROPE NV
BP. BP P.L.C.
BSGR B&S GROUP S.A.
NXFIL NX FILTRATION HLDG BV
AERO MONTANA AEROSPACE AG
OVH OVH GROUPE
SHEL SHELL PLC
IOS IONOS GROUP SE
AF AIR FRANCE - KLM
LOUP SOCIETE L.D.C.
- Ahmed Ben Salem
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
ADS ADIDAS AG
PUM PUMA SE
F3C SFC ENERGY AG
ENI ENI S.P.A.
REP REPSOL SA
CCC CCC SA
SAE SHOP APOTHEKE EUROPE NV
BP. BP P.L.C.
NXFIL NX FILTRATION HLDG BV
AERO MONTANA AEROSPACE AG
OVH OVH GROUPE
SHEL SHELL PLC
IOS IONOS GROUP SE
AF AIR FRANCE - KLM
LOUP SOCIETE L.D.C.
- Usama Tariq
- Wim Gille
- Guy Sips
- Jacob Mekhael
- Kristof Samoy
- Wim Hoste
- Wim Lewi
- Kristof Samoy
NX Filtration FY24 earnings release held little news value, all eyes o...
In mid-December, NX Filtration reported that revenues for 2024 would only grow ca. 40% and issued a revenue guidance for 2025, projecting growth between 50-70% well below our and consensus estimates. Sequentially, revenues for the second half of 2024 were down 15%, with year-over-year growth for 2H24 at only 7%. Supported by sustained high gross margins and flat FTEs compared to 1H24, the EBITDA loss for 2H24 ‘only' widened to €-9.6m, compared to €-6.4m in 1H24. We have revised our model, upgrad...
- Bruno Cavalier
- Christophe-Raphaël Ganet
- Oliver Metzger
LHA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
PROX PROXIMUS SA DE DROIT PUBLIC
MC LVMH MOET HENNESSY LOUIS VUITTON SE
BFIT BASIC-FIT NV
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
SCR SCOR SE
GXI GERRESHEIMER AG
EL ESSILORLUXOTTICA SA
IAG INTERNATIONAL CONSOLIDATED AIRLINES GROUP SA
BRBY BURBERRY GROUP PLC
KER KERING SA
WIZZ WIZZ AIR HOLDINGS PLC
GN GN STORE NORD A/S
EZJ EASYJET PLC
RY4C RYANAIR HOLDINGS PLC
01913 PRADA S.P.A.
SAVE SAVENCIA SA
LPP LPP S.A.
MONC MONCLER SPA
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
SAB BANCO DE SABADELL SA
NXFIL NX FILTRATION HLDG BV
IVG IVECO GROUP
AF AIR FRANCE - KLM
- Bruno Cavalier
- Christophe-Raphaël Ganet
- Oliver Metzger
LHA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
PROX PROXIMUS SA DE DROIT PUBLIC
MC LVMH MOET HENNESSY LOUIS VUITTON SE
BFIT BASIC-FIT NV
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
SCR SCOR SE
GXI GERRESHEIMER AG
EL ESSILORLUXOTTICA SA
IAG INTERNATIONAL CONSOLIDATED AIRLINES GROUP SA
BRBY BURBERRY GROUP PLC
KER KERING SA
WIZZ WIZZ AIR HOLDINGS PLC
GN GN STORE NORD A/S
EZJ EASYJET PLC
RY4C RYANAIR HOLDINGS PLC
01913 PRADA S.P.A.
SAVE SAVENCIA SA
LPP LPP S.A.
MONC MONCLER SPA
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
SAB BANCO DE SABADELL SA
NXFIL NX FILTRATION HLDG BV
IVG IVECO GROUP
AF AIR FRANCE - KLM
- Usama Tariq
- Wim Gille
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Michiel Declercq
- Thomas Couvreur
- Wim Lewi
- Baptiste Salaville
- Bruno Cavalier
- Charlotte Vaisse
- Jerôme Bodin
FME FRESENIUS MEDICAL CARE AG
LHA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
1COV COVESTRO AG
FRA FRAPORT AG
TKA THYSSENKRUPP AG
WCH WACKER CHEMIE AG
ADS ADIDAS AG
G1A GEA GROUP AG
MC LVMH MOET HENNESSY LOUIS VUITTON SE
MTX MTU AERO ENGINES AG
CBK COMMERZBANK AG
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
DAI DAIMLER AG
GBF BILFINGER SE
RHM RHEINMETALL AG
LXS LANXESS AG
GXI GERRESHEIMER AG
EL ESSILORLUXOTTICA SA
KCO KLOECKNER & CO SE
PSM PROSIEBENSAT.1 MEDIA SE
BRBY BURBERRY GROUP PLC
MRK MERCK KGAA
KER KERING SA
BOSS HUGO BOSS AG
SDF K+S AG
NOEJ NORMA GROUP SE
FR VALEO SE
PNL POSTNL NV
BAS BASF SE
BAYN BAYER AG
VOW3 VOLKSWAGEN AG PREF
HEN3 HENKEL AG & CO. KGAA PREF
DTE DEUTSCHE TELEKOM AG
SY1 SYMRISE AG
01913 PRADA S.P.A.
CFEB COMPAGNIE D'ENTREPRISES CFE SA
DEZ DEUTZ AG
AIXA AIXTRON SE
KRN KRONES AG
NEM NEMETSCHEK SE
SAX STROEER SE & CO. KGAA
EVK EVONIK INDUSTRIES AG
KGX KION GROUP AG
MONC MONCLER SPA
BNR BRENNTAG SE
FYB FORMYCON AG
SMHN SUESS MICROTEC AG
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
JUN3 JUNGHEINRICH AG PREF
DUE DURR AG
JST JOST WERKE AG
SHL SIEMENS HEALTHINEERS AG
S92 SMA SOLAR TECHNOLOGY AG
JEN JENOPTIK AG
KBX KNORR-BREMSE AG
HAG HENSOLDT AG
NXFIL NX FILTRATION HLDG BV
FPE3 FUCHS PETROLUB SE
DTG DAIMLER TRUCK
STM STABILUS SE
TUI TUI AG
SCHOTT PHARMA AG
R3NK RENK GROUP AG
QGEN QIAGEN N.V.
SHA SCHAEFFLER AG
- Baptiste Salaville
- Charlotte Vaisse
- Jerôme Bodin
FME FRESENIUS MEDICAL CARE AG
LHA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
1COV COVESTRO AG
FRA FRAPORT AG
TKA THYSSENKRUPP AG
WCH WACKER CHEMIE AG
ADS ADIDAS AG
G1A GEA GROUP AG
MC LVMH MOET HENNESSY LOUIS VUITTON SE
MTX MTU AERO ENGINES AG
CBK COMMERZBANK AG
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
DAI DAIMLER AG
GBF BILFINGER SE
RHM RHEINMETALL AG
LXS LANXESS AG
GXI GERRESHEIMER AG
EL ESSILORLUXOTTICA SA
KCO KLOECKNER & CO SE
PSM PROSIEBENSAT.1 MEDIA SE
BRBY BURBERRY GROUP PLC
MRK MERCK KGAA
KER KERING SA
BOSS HUGO BOSS AG
SDF K+S AG
NOEJ NORMA GROUP SE
FR VALEO SE
PNL POSTNL NV
BAS BASF SE
BAYN BAYER AG
VOW3 VOLKSWAGEN AG PREF
HEN3 HENKEL AG & CO. KGAA PREF
DTE DEUTSCHE TELEKOM AG
SY1 SYMRISE AG
01913 PRADA S.P.A.
CFEB COMPAGNIE D'ENTREPRISES CFE SA
DEZ DEUTZ AG
AIXA AIXTRON SE
KRN KRONES AG
NEM NEMETSCHEK SE
SAX STROEER SE & CO. KGAA
EVK EVONIK INDUSTRIES AG
KGX KION GROUP AG
MONC MONCLER SPA
BNR BRENNTAG SE
SMHN SUESS MICROTEC AG
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
JUN3 JUNGHEINRICH AG PREF
DUE DURR AG
JST JOST WERKE AG
SHL SIEMENS HEALTHINEERS AG
S92 SMA SOLAR TECHNOLOGY AG
JEN JENOPTIK AG
KBX KNORR-BREMSE AG
HAG HENSOLDT AG
NXFIL NX FILTRATION HLDG BV
FPE3 FUCHS PETROLUB SE
DTG DAIMLER TRUCK
STM STABILUS SE
TUI TUI AG
SCHOTT PHARMA AG
R3NK RENK GROUP AG
QGEN QIAGEN N.V.
SHA SCHAEFFLER AG
- Usama Tariq
- Wim Gille
- Usama Tariq
- Wim Gille
- Kristof Samoy
NX Filtration Lowering revenue guidance again
This morning NXFIL warned the markets its FY24 revenue guidance has been lowered to €10.5-€11.5m while previous guidance called for revenues in excess of €16m. For 2025 the company now calls for revenue growth of 50% to 70% based on its commercial pipeline. Applying 60% growth on the midpoint of the lowered FY24 guidance yields 17.6m revenues for 2025 well below yesterdays Refinitiv consensus revenues of €37.3m and KBC forecasts of €28.6m for 2025. We reiterate reduce rating and € 3.3 target pri...
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Wim Lewi
- Guy Sips
- Kristof Samoy
- Lynn Hautekeete
- Michiel Declercq
- Thibault Leneeuw
- Thomas Couvreur
- Kristof Samoy
NX Filtration HF UF contract win in Saudi Arabia
This morning NXFIL announced a contract win for 800 modules of HF UF modules to Kindasa Water Services (KWS), a private potable water supplier in Saudi Arabia. The order relates to UF membranes and not the high(er) margin dNF membrane modules. We estimate linked revenue recognition in 2024 to be around €1.2m.
- Kristof Samoy
NX Filtration 1H24 results & analyst call key take-aways
Mid July NXFIL already informed the markets on its 1H24 revenues when it communicated the appointment of a new CEO. 1H24 revenues landed at €5.9m growing 56% with gross margins maintained at a high 59%. FTE's were flat vs. year end 2023. EBITDA stood at €-6.4m (vs. €-5.3m in 1H23). Guidance remained unchanged calling for revenues >€16m.
- Martijn Den Drijver
ODDO BHF Small & MIDCAP MORNING NEWS - 08/28/2024
We initiate the coverage of Ypsomed with a target price of CHF 495 and an Outperform rating. As a leading developer and manufacturer of a broad portfolio of injection systems for the self-medication of liquid drugs, Ypsomed will benefit from major trends in the healthcare industry. The company is currently in a transformation process to exit non-core activities and to focus on the fast-growing and highly profitable Delivery Systems business. This is expected to lead on our estimates t...
- Martijn Den Drijver
ODDO BHF Small & MIDCAP MORNING NEWS - 28/08/2024
We initiate the coverage of Ypsomed with a target price of CHF 495 and an Outperform rating. As a leading developer and manufacturer of a broad portfolio of injection systems for the self-medication of liquid drugs, Ypsomed will benefit from major trends in the healthcare industry. The company is currently in a transformation process to exit non-core activities and to focus on the fast-growing and highly profitable Delivery Systems business. This is expected to lead on our estimates t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.